Rebonuputemcel
AssetAlso IDCT, Discogenic Cells
Allogeneic disc-derived progenitor cell therapy for disc regeneration
- Stage
- Phase 3
- Modality
- Cell therapy
- Target
- Stem cell maintenance
- 1
- Indication
- 3
- Trials
- 1
- Developer
Indications
1Degenerative disc disease
Phase 3, Recruiting, NCT07254806, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials3
- Evidence for its targets1
- Competitors3
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026, 4 sources